期刊文献+

胃癌病人血清IL-2R、IL-10、IL-12水平的变化 被引量:2

Changes of Serum Soluble Interleukin-2 Receptor,Interleukin-10and Interleukin-12 in Patients with Gastric Cancer
下载PDF
导出
摘要 [目的]观察胃癌病人血清可溶性白介素2受体(sIL 2R)、白介素10(IL 10)、白介素12(IL 12)表达水平的变化。[方法]A组(正常对照组)12例 ,B组(胃癌带瘤组)22例 ,C组(胃癌术后半年内无复发组)20例 ,D组(胃癌术后半年以上无复发组)21例 ,ELISA法检测各组血清IL 2R、IL 10、IL 12水平。[结果]与A组相比 ,B组的IL 2R水平明显升高(P<0.005) ,B、C组的IL 12水平明显降低(P<0.005) ,与B组相比 ,D组的IL 2R水平明显降低(P<0.005) ,IL 12水平明显回升(P<0.05)。IL 12水平与IL 2R、IL 10水平无明显相关性。[结论]胃癌病人血清IL 2R水平升高 ,IL 12水平降低 ,根除肿瘤后IL 2R、IL To observe the changes of serum interleukin 2 receptor (IL_2R),interleukin_10 (IL_10) and interleukin_12 (IL 12)in patients with gastric cancer.Patients were divided into four groups:group A(normal control,12 cases),group B(patients with gastric cancer burden,22 cases),group C(patients without recurrence within half a year after resection of gastric cancer,20 cases),group D(patients without recurrence beyond half a year after resection of gastric cancer,21 cases).Serum level of IL 2R,IL 10 and IL 12 were assayed by ELISA.Compared with group A,serum IL 2R in group B increased significantly (P<0.005),and IL 12 in group B and group C decreased significantly (P<0.005).Compared with group B,IL 2R in group D increased significantly (P<0.005),and IL 12 increased significantly(P<0.05).No obvious correlation between the level of IL 12 and IL 2R or IL 10 was found.[Conclusion]In patients with gastric cancer,serum IL 2R increased and IL 12 decreased.After tumor eradicated curative IL 2R and IL 12 will return to normal level gradually.
出处 《肿瘤学杂志》 CAS 2001年第6期343-345,共3页 Journal of Chinese Oncology
关键词 白细胞介素2受体 白细胞介素 IL-10 胃癌 gastric neoplasms receptor,interleukin 2 interleukin
  • 相关文献

参考文献1

  • 1A. M. Berghella,Patrizia Pellegrini,Tiziana Del Beato,Matteo Marini,Ennio Tomei,Domenico Adorno,Carlo Umberto Casciani. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back[J] 1997,Cancer Immunology, Immunotherapy(5):241~249

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部